共 50 条
- [42] Pirfenidone vs nintedanib for treatment of idiopathic pulmonary fibrosis in clinical practice: efficacy, tolerability, and adverse effects EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (03): : 549 - 559
- [44] Development and utility of pirfenidone in the treatment of idiopathic pulmonary fibrosis: review of preclinical science and recent clinical trials TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2011, 3 : 55 - 63
- [45] Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2015, 2 (01):